Page last updated: 2024-12-11

alpha-cyperone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-cyperone: isolated from the rhizomes of Cyperus rotundus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CyperusgenusA plant genus of the family CYPERACEAE. SESQUITERPENES are found in some of the species.[MeSH]CyperaceaeThe sedge plant family of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons)[MeSH]

Cross-References

ID SourceID
PubMed CID6452086
CHEMBL ID1939885
SCHEMBL ID8170833
MeSH IDM0588381

Synonyms (30)

Synonym
alpha-cyperone
C17090
473-08-5
(4as,7r)-1,4a-dimethyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one
zl24sg1c2d ,
2(3h)-naphthalenone, 4,4a,5,6,7,8-hexahydro-1,4a-dimethyl-7-(1-methylethenyl)-, (4as-cis)-
unii-zl24sg1c2d
S9236
CHEMBL1939885
AKOS015916225
eudesma-4,11-dien-3-one
SCHEMBL8170833
.alpha.-cyperone
alpha cyperone
HY-N0710
DTXSID60197086
(4as,7r)-1,4a-dimethyl-7-(prop-1-en-2-yl)-2,3,4,4a,5,6,7,8-octahydronaphthalen-2-one
AS-74261
CS-5967
(4as,7r)-1,4a-dimethyl-7-(prop-1-en-2-yl)-4,4a,5,6,7,8-hexahydronaphthalen-2(3h)-one
mfcd09839027
4,11-selinadien-3-one
(+)-alpha cyperone
(-)-alpha cyperone
CCG-266713
a-cyperone
(+)-a-cyperone
2(3h)-naphthalenone,4,4a,5,6,7,8-hexahydro-1,4a-dimethyl-7-(1-methylethenyl)-, (4as,7r)-
-cyperone;(+)--cyperone
AC-34878
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID642414Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID1634809Antagonist activity at human ORAI1 expressed in HEK293T cells assessed as capsaicin-induced inwardly rectifying current at 90 uM and -120 mV by whole cell patch-clamp method relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Valencene from the Rhizomes of Cyperus rotundus Inhibits Skin Photoaging-Related Ion Channels and UV-Induced Melanogenesis in B16F10 Melanoma Cells.
AID642415Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID1634805Antagonist activity at human TRPV1 expressed in HEK293T cells assessed as capsaicin-induced inward transient currents at 90 uM and -60 mV by whole cell patch-clamp method relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Valencene from the Rhizomes of Cyperus rotundus Inhibits Skin Photoaging-Related Ion Channels and UV-Induced Melanogenesis in B16F10 Melanoma Cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (56.25)24.3611
2020's7 (43.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.50 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]